Market commentary
-
Farewell 2020, Hello 2021
David Buckland
January 4, 2021
Sunday, 8 March 2020, was not only International Women’s Day, but the ICC Women’s World T20 Cricket final, played between Australia and India at the Melbourne Cricket Ground, attended by over 86,000 spectators. (Australia won by 85 runs). Ten months later, over 85 million people globally have been infected and 1.85 million people have passed-away from COVID-19. continue…
by David Buckland Posted in Market commentary.
- save this article
- POSTED IN Market commentary
-
Why I think share markets will boom in 2021
Roger Montgomery
December 15, 2020
As 2020 draws to a close, the finance world is awash with market commentators making bold predictions for the year ahead. For what it’s worth, here’s mine: I think 2021 could see a surge in asset prices driven by the rollout of a COVID-19 vaccine, loose money supply and pent-up consumer demand. continue…
by Roger Montgomery Posted in Editor's Pick, Market commentary.
-
A review of markets in 2020
Joseph Kim
December 15, 2020
With 2020 almost now behind us, I thought it was worthwhile looking at the year that was. It’s safe to say this year is unlikely to be forgotten for everyone, and not just those invested in equity markets. After a very strong January, investors and markets grappled with the uncertainty and severe volatility brought upon by COVID-19’s spread around the world. continue…
by Joseph Kim Posted in Market commentary.
- save this article
- POSTED IN Market commentary
-
Turn over these stones in 2021
Roger Montgomery
December 14, 2020
While 2020 will always be remembered for the global lockdowns associated with COVID-19, many will also remember it was the year the Reserve Bank of Australia’s monetary policy acquiesced to the big momentum of Modern Monetary Theory. It was the year the RBA embraced an assortment of avant-garde actions in a continuation of the measures adopted by its contemporaries, since the GFC, in most other jurisdictions. continue…
by Roger Montgomery Posted in Editor's Pick, Market commentary.
- save this article
- POSTED IN Editor's Pick, Market commentary
-
How to position your portfolio for a post-COVID boom
Roger Montgomery
December 8, 2020
The good news on COVID-19 vaccines strengthens the case for a global equities boom in 2021. But where will the biggest gains be found? In beaten-down cyclicals, ‘re-openers’ and other firms smashed by the temporary lockdowns? Or in the so-called ‘pandemic darling’ tech stocks? continue…
by Roger Montgomery Posted in Editor's Pick, Market commentary.
- save this article
- POSTED IN Editor's Pick, Market commentary
-
WHITEPAPER
INTEREST RATES, THE BEST IT GETS. IT’S TIME TO DEPLOY CASH
Curious about the investment landscape in 2024? It appears that the current market offers a plethora of enticing opportunities for investors, a rarity not experienced since pre-pandemic times. This unique scenario stems from a confluence of factors, including elevated yields and comparatively rational equity valuations.
READ HERE -
Why our soaring market still looks ok to me
Roger Montgomery
December 3, 2020
Are share markets cheap or expensive right now? Well, it depends who you ask. And there are plenty of people happy to offer their opinion. But at the risk of adding to this largely irrelevant discussion (after all, we buy shares in companies, not ‘the market’) here’s my take. Please feel free to comment – I’d love to read your views as well. continue…
by Roger Montgomery Posted in Market commentary.
- 16 Comments
- save this article
- POSTED IN Market commentary
-
Looking across the earnings valley
David Buckland
November 20, 2020
Those companies which record the largest retreat in profitability during a recession often see the biggest rebounds in subsequent years. Company reports and consensus Earning Per Share (EPS) estimates for the US S&P500 market points to a similar experience for this cycle. continue…
by David Buckland Posted in Market commentary.
- 2 Comments
- save this article
- POSTED IN Market commentary
-
Winners and losers from vaccine announcements
Joseph Kim
November 17, 2020
In a year full of big moves and volatile share prices, last Tuesday saw one of the biggest disparities in the share price performance of the so called “growth vs value” stocks. The spark was the announcement from the Pfizer and BioNTech’s vaccine, which led to a significant rotation into the traditional “value” stocks, funded largely by profit taking in many growth stocks. continue…
by Joseph Kim Posted in Companies, Market commentary.
- save this article
- POSTED IN Companies, Market commentary
-
How Pfizer’s vaccine will affect stocks in your portfolio
Roger Montgomery
November 12, 2020
Wow, what a week! Pfizer announces it has a vaccine almost set to go, and hasn’t the market reacted! Happily for our investors, The Montgomery Fund has already pivoted towards a post-pandemic world: we’ve cut cash to a record low and invested in some businesses beaten down by enforced lockdowns. continue…
by Roger Montgomery Posted in Global markets, Market commentary.
-
Why growth stocks could keep rising
Roger Montgomery
October 27, 2020
The share prices of growth companies – particularly quality businesses such as the much heralded FAAMGs – have been on a tear since March. How much further could they go? Well, quite a bit further I think, if rates stay low and governments keep providing financial support. continue…
by Roger Montgomery Posted in Global markets, Market commentary.
